Cite
HARVARD Citation
Maher, T. et al. (n.d.). FRI0301 GASTROINTESTINAL ADVERSE EVENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) TREATED WITH NINTEDANIB: DATA FROM THE SENSCIS TRIAL. Annals of the rheumatic diseases. pp. 831-832. [Online].